Filtering by:
TreatmentFDA Approves Ayvakit (Avapritinib) for GIST
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.
FDA Approves Padcev (Enfortumab vedotin-ejfv) for Bladder Cancer
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
Study: Hormone Treatment for Prostate Cancer Linked With Dementia
Researchers from the University of Pennsylvania found that older prostate cancer patients getting hormone treatment, called androgen deprivation therapy (ADT), were more likely to be diagnosed later with Alzheimer’s disease or dementia.
Studies Find Open Surgery Safer For Early Cervical Cancer
Researchers at the University of Texas MD Anderson Cancer Center and colleagues find that women who undergo minimally invasive radical hysterectomy to treat early-stage cervical cancer have worse outcomes than women who undergo abdominal “open” radical hysterectomy.
Study Supports Immunotherapy for Treating Triple-Negative Breast Cancer
A study by an international group of researchers has found for the first time that a combination of immunotherapy and chemotherapy can extend lives of women with triple-negative breast cancer.